Log in to save to my catalogue

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal ca...

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b88c275529fe4c4da1b6cfc8c63c7d7e

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

About this item

Full title

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

Publisher

London: Nature Publishing Group UK

Journal title

NPJ breast cancer, 2021-12, Vol.7 (1), p.156-156, Article 156

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

When molecular testing classifies breast tumors as low risk but clinical risk is high, the optimal management strategy is unknown. One group of patients who may be more likely to have such discordant risk are those with invasive lobular carcinoma of the breast. We sought to examine whether patients with invasive lobular carcinoma are more likely to...

Alternative Titles

Full title

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b88c275529fe4c4da1b6cfc8c63c7d7e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b88c275529fe4c4da1b6cfc8c63c7d7e

Other Identifiers

ISSN

2374-4677

E-ISSN

2374-4677

DOI

10.1038/s41523-021-00366-x

How to access this item